The mean C5a levels were higher in COVID-19 patients by 30.5 ng/ml (95% 0.4–60.7) compared to patients with bacterial sepsis (p = 0.047), adjusted for age, sex, and APACHE II. This evidence concerns the gene C5 and COVID-19.